Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/20000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human TCF3. AA range:571-620
Subcellular Location
Nucleus .
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
6929
Observed Band
68kD
Other Name
BHLHB21
Class B basic helix-loop-helix protein 21
E2A
ITF1
Immunoglobulin enhancer-binding factor E12/E47
Immunoglobulin transcription factor 1
Kappa-E2-binding factor
TCF3
Transcription facto
Transcription factor E2-alpha
bHLHb21
Class B basic helix-loop-helix protein 21
E2A
ITF1
Immunoglobulin enhancer-binding factor E12/E47
Immunoglobulin transcription factor 1
Kappa-E2-binding factor
TCF3
Transcription facto
Transcription factor E2-alpha
bHLHb21
Background
19), with PBX1), childhood leukemia (t(19
19), with TFPT) and acute leukemia (t(12
19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have bee
This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodi
19), with TFPT) and acute leukemia (t(12
19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have bee
This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodi